GlassScriptPhysician profile
Leonard A Feitell
NPI 1396745949
$920.19
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $202 · 2021: $149 · 2022: $243 · 2023: $28.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $214.90 | 2019-2020 | |
| Amgen INC. | $76.48 | 2019-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $73.45 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $66.25 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $56.06 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.52 | 2022 | |
| Novartis Pharmaceuticals Corporation | $53.42 | 2020-2022 | |
| Pfizer INC. | $52.00 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $50.83 | 2022 | |
| Arbor Pharmaceuticals, INC. | $35.73 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.37 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.50 | 2022-2023 | Eliquis |
| Eisai INC. | $27.02 | 2021 | |
| Esperion Therapeutics, INC. | $21.02 | 2022 | |
| Becton, Dickinson and Company | $16.06 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.96 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.77 | 2022 | |
| Amarin Pharma, INC. | $13.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Feitell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.